34 related articles for article (PubMed ID: 37173384)
1. YY1 modulates the radiosensitivity of esophageal squamous cell carcinoma through KIF3B-mediated Hippo signaling pathway.
Zheng C; Li Z; Zhao C; Yin X; Feng L; Wang Z; Liu C; Li B
Cell Death Dis; 2023 Dec; 14(12):806. PubMed ID: 38065955
[TBL] [Abstract][Full Text] [Related]
2. ZNF468 inhibits irradiation-induced G2/M cell cycle arrest and apoptosis by facilitating AURKA transcription in Esophageal Squamous Cell Carcinoma.
Bai G; Mahati S; Tulahong A; Eli M; Mao R
Biochem Biophys Res Commun; 2024 Apr; 703():149687. PubMed ID: 38368674
[TBL] [Abstract][Full Text] [Related]
3. The AEG-1-USP10-PARP1 axis confers radioresistance in esophageal squamous cell carcinoma via facilitating homologous recombination-dependent DNA damage repair.
Zhao X; Ma Y; Li J; Sun X; Sun Y; Qu F; Shi X; Xie Y; Liu S; Ma Y; Ji C; Hu W; Che S; Zhang X
Cancer Lett; 2023 Nov; 577():216440. PubMed ID: 37838281
[TBL] [Abstract][Full Text] [Related]
4. FOXK1 upregulation is correlated with tumor progression and tumor associated macrophages infiltration in renal cell carcinoma.
Chen S; Pan X; Zhang L; Cui X; Ye J
Mol Carcinog; 2024 Jan; 63(1):136-144. PubMed ID: 37818826
[TBL] [Abstract][Full Text] [Related]
5. Collagen 1-mediated CXCL1 secretion in tumor cells activates fibroblasts to promote radioresistance of esophageal cancer.
Yang X; Chen X; Zhang S; Fan W; Zhong C; Liu T; Cheng G; Zhu L; Liu Q; Xi Y; Tan W; Lin D; Wu C
Cell Rep; 2023 Oct; 42(10):113270. PubMed ID: 37851572
[TBL] [Abstract][Full Text] [Related]
6. FOXO3a-regulated arginine metabolic plasticity adaptively promotes esophageal cancer proliferation and metastasis.
Sun W; Kou H; Fang Y; Xu F; Xu Z; Wang X; Yin R; Zhang Q; Jiang Q; Xu Y
Oncogene; 2024 Jan; 43(3):216-223. PubMed ID: 38049565
[TBL] [Abstract][Full Text] [Related]
7. Novel interactions between FOXM1 and CDC25A regulate the cell cycle.
Sullivan C; Liu Y; Shen J; Curtis A; Newman C; Hock JM; Li X
PLoS One; 2012; 7(12):e51277. PubMed ID: 23240008
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of radiotherapy resistance and radiosensitization strategies for esophageal squamous cell carcinoma.
An L; Li M; Jia Q
Mol Cancer; 2023 Aug; 22(1):140. PubMed ID: 37598158
[TBL] [Abstract][Full Text] [Related]
9. TFAP4 promotes the growth of prostate cancer cells by upregulating FOXK1.
Gu Y; Jiang J; Liang C
Exp Ther Med; 2021 Nov; 22(5):1299. PubMed ID: 34630654
[TBL] [Abstract][Full Text] [Related]
10. Revealing the oncogenic role of elevated GNL3L expression in esophageal squamous cell carcinoma: insights into the STAT3 pathway.
Yu S; Zhang P; Xu S; Xiang Z; Madan A; Eslick GD; Dayyani F; Chen S
J Thorac Dis; 2024 Apr; 16(4):2580-2590. PubMed ID: 38738247
[TBL] [Abstract][Full Text] [Related]
11. FOXK1 promotes hormonally responsive breast carcinogenesis by suppressing apoptosis.
Zhao M; Ma T; Zhang Z; Wang Y; Wang X; Wang W; Chen X; Gao R; Shan L
Animal Model Exp Med; 2024 Jan; ():. PubMed ID: 38238876
[TBL] [Abstract][Full Text] [Related]
12. Androgen Receptor/AP-1 Activates
Cai J; Huang F; Gao W; Gong T; Chen H; Liu Z
Cancers (Basel); 2023 Dec; 15(24):. PubMed ID: 38136265
[TBL] [Abstract][Full Text] [Related]
13. FoxK1 associated gene regulatory network in hepatic insulin action and its relationship to FoxO1 and insulin receptor mediated transcriptional regulation.
Allu PKR; Cardamone MD; Gomes AS; Dall'agnese A; Cederquist C; Pan H; Dreyfuss JM; Enerbäck S; Kahn CR
Mol Metab; 2023 Dec; 78():101825. PubMed ID: 37852413
[TBL] [Abstract][Full Text] [Related]
14. O-GlcNAcylation of FOXK1 orchestrates the E2F pathway and promotes oncogenesis.
Masclef L; Ahmed O; Iannantuono N; Gagnon J; Gushul-Leclaire M; Boulay K; Estavoyer B; Echbicheb M; Poy M; Boubacar KA; Boubekeur A; Menggad S; Schcolnik-Cabrera A; Balsalobre A; Bonneil E; Thibault P; Hulea L; Tanaka Y; Antoine-Mallette F; Drouin J; Affar EB
bioRxiv; 2024 Mar; ():. PubMed ID: 38463952
[TBL] [Abstract][Full Text] [Related]
15. Domperidone inhibits cell proliferation via targeting MEK and CDK4 in esophageal squamous cell carcinoma.
Yuan Q; Shi Y; Zhang Y; Shi Y; Hussain Z; Zhao J; Jiang Y; Qiao Y; Guo Y; Lu J; Dong Z; Dong Z; Wang J; Liu K
Cancer Cell Int; 2024 Mar; 24(1):114. PubMed ID: 38528618
[TBL] [Abstract][Full Text] [Related]
16. Radiotherapy combined with immune checkpoint inhibitors in locally advanced/metastatic esophageal squamous cell carcinoma: clinical trials, efficacy and future directions.
Jiang M; Hu Y; Lin G; Chen C; Li H
Front Immunol; 2023; 14():1177085. PubMed ID: 37325652
[TBL] [Abstract][Full Text] [Related]
17. Spatial distribution of tumor-infiltrating T cells indicated immune response status under chemoradiotherapy plus PD-1 blockade in esophageal cancer.
Yan C; Huang H; Zheng Z; Ma X; Zhao G; Zhang T; Chen X; Cao F; Wei H; Dong J; Tang P; Jiang H; Wang M; Wang P; Pang Q; Zhang W
Front Immunol; 2023; 14():1138054. PubMed ID: 37275884
[TBL] [Abstract][Full Text] [Related]
18. Glutathione-Exhausting Nanoprobes for NIR-II Fluorescence Imaging-Guided Surgery and Boosting Radiation Therapy Efficacy via Ferroptosis in Breast Cancer.
Wei M; Bai J; Shen X; Lou K; Gao Y; Lv R; Wang P; Liu X; Zhang G
ACS Nano; 2023 Jun; 17(12):11345-11361. PubMed ID: 37272787
[TBL] [Abstract][Full Text] [Related]
19. FOXK1 regulates malignant progression and radiosensitivity through direct transcriptional activation of CDC25A and CDK4 in esophageal squamous cell carcinoma.
Li X; Lu J; Liu L; Li F; Xu T; Chen L; Yan Z; Li Y; Guo W
Sci Rep; 2023 May; 13(1):7737. PubMed ID: 37173384
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
